Skip to content

Kelly Thomas Patrick Insider Trading -- Recent SEC Form 4 Transactions

Kelly Thomas Patrick (CIK 1410514) reported 1 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-10-01). Recent activity: Buy XENE (15,000 shares). Source: SEC Form 4.

DateCompanyRoleTypeSharesValue
2026-10-01Xenon Pharmaceuticals Inc. (XENE)Chief Financial OfficerBuy15,000$559,740

Source: SEC Form 4 filings · as of 2026-10-01